These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 3038733

  • 1. [Sulbactam and clavulanic acid: studies of enzyme kinetics and synergism with ampicillin and mezlocillin].
    Cullmann W, Binder S, Stieglitz M.
    Immun Infekt; 1987 May; 15(3):103-9. PubMed ID: 3038733
    [Abstract] [Full Text] [Related]

  • 2. Sulbactam and clavulanic acid: enzyme kinetics and synergy with ampicillin and mezlocillin.
    Cullmann W, Binder S, Stieglitz M.
    Int J Antimicrob Agents; 1996 Apr; 6 Suppl():S1-7. PubMed ID: 18611714
    [Abstract] [Full Text] [Related]

  • 3. Interaction of clavulanic acid, sulbactam and cephamycin antibiotics with beta-lactamases.
    Grace ME, Fu KP, Gregory FJ, Hung PP.
    Drugs Exp Clin Res; 1987 Apr; 13(3):145-8. PubMed ID: 3040368
    [Abstract] [Full Text] [Related]

  • 4. Sulbactam and clavulanic acid: studies of enzyme kinetics and synergy with ampicillin and mezlocillin.
    Cullmann W, Stieglitz M, Opferkuch W.
    Drugs; 1988 Apr; 35 Suppl 7():71-6. PubMed ID: 3220009
    [No Abstract] [Full Text] [Related]

  • 5. [In vitro comparison of the beta lactamase-inhibitory action of clavulanic acid and sulbactam in ampicillin-resistant enterobacteria].
    Grimm H.
    Arzneimittelforschung; 1987 Oct; 37(10):1116-9. PubMed ID: 3501722
    [Abstract] [Full Text] [Related]

  • 6. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    Sader HS, Tosin I, Sejas L, Miranda E.
    Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
    [Abstract] [Full Text] [Related]

  • 7. Effect of five irreversible inhibitors on beta-lactamase from Shigella flexneri UCSF-129.
    Campos M, Alarcón MA, González H, Sánchez R.
    Microbios; 1993 Feb; 76(308):171-9. PubMed ID: 8302198
    [Abstract] [Full Text] [Related]

  • 8. Relative efficacy of tazobactam, sulbactam and clavulanic acid in enhancing the potency of ampicillin against clinical isolates of Enterobacteriaceae.
    Pfaller M, Barry A, Fuchs P, Gerlach E, Hardy D, McLaughlin J.
    Eur J Clin Microbiol Infect Dis; 1993 Mar; 12(3):200-5. PubMed ID: 8389705
    [Abstract] [Full Text] [Related]

  • 9. In vitro activity against clinically important gram-positive and gram-negative bacteria of sulbactam, alone and in combination with ampicillin, cefotaxime, mezlocillin, and piperacillin.
    Schmalreck AF, Wildfeuer A.
    Arzneimittelforschung; 1990 Oct; 40(10):1145-55. PubMed ID: 2291754
    [Abstract] [Full Text] [Related]

  • 10. Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanic acid and sulbactam combined with ampicillin and piperacillin against beta-lactamase producing anaerobic bacteria.
    Nord CE.
    J Chemother; 1989 Jul; 1(4 Suppl):273-5. PubMed ID: 16312398
    [No Abstract] [Full Text] [Related]

  • 11. Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with ampicillin and broad-spectrum penicillins against defined beta-lactamase-producing aerobic gram-negative bacilli.
    Jacobs MR, Aronoff SC, Johenning S, Shlaes DM, Yamabe S.
    Antimicrob Agents Chemother; 1986 Jun; 29(6):980-5. PubMed ID: 3015017
    [Abstract] [Full Text] [Related]

  • 12. Beta-lactamase inhibition by acetylmethylene penicillanic acid compared to that of clavulanate and sulbactam.
    Chin NX, McElrath MJ, Neu HC.
    Chemotherapy; 1988 Jun; 34(4):318-25. PubMed ID: 2850139
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Interaction of beta-lactamase inhibitors with various beta-lactamases.
    Cullmann W.
    Chemotherapy; 1990 Jun; 36(3):200-8. PubMed ID: 2159863
    [Abstract] [Full Text] [Related]

  • 16. Development of beta-lactamase inhibitors.
    Sutherland R.
    J Reprod Med; 1990 Mar; 35(3 Suppl):307-12. PubMed ID: 2319512
    [Abstract] [Full Text] [Related]

  • 17. Detection, distribution and inhibition of Branhamella catarrhalis beta-lactamases.
    Philippon A, Riou JY, Guibourdenche M, Sotolongo F.
    Drugs; 1986 Mar; 31 Suppl 3():64-9. PubMed ID: 3015547
    [Abstract] [Full Text] [Related]

  • 18. Bacteriological investigations with beta-lactamase inhibitors.
    Ullmann U.
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):222-9. PubMed ID: 6289565
    [Abstract] [Full Text] [Related]

  • 19. Induction/inhibition of chromosomal beta-lactamases by beta-lactamase inhibitors.
    Moosdeen F, Keeble J, Williams JD.
    Rev Infect Dis; 1986 Jun; 8 Suppl 5():S562-8. PubMed ID: 3026004
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.